The Sackler family's opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Their Purdue Pharma company is in bankruptcy, but the family continues to profit from sales of their signature painkiller OxyContin abroad. Sales reps at their international affiliate, Mundipharma, have been chasing profits in China using many of the same tactics that Purdue was forced to abandon in the U.S. as the death toll from opioid overdoses soared, interviews and documents obtained by the AP show. Here are key findings from those documents and interviews.
Chemical Name |
Synonyms |
Molecular Formula |
Molecular Weight |
---|
Product Name | Innovator |
---|
Product Name | Market Status |
---|
Product Name | Indication |
---|
Product Name | Therapeutic Segment |
---|
Your product will be updated soon in our database